stockrow
Saturday 7 November 2026
Export DNMX’s income statement to Excel — free account
Dynamix Corporation III
DNMX Financial Shell Companies
10.11
0.00
0.00%
Follow DNMX
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Gross margin, % | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EBT | — | — | — | — | — | — | — | — | — | 1 | — | — | ||||||
| EBT margin, % | — | — | — | — | — | — | — | — | — | 0.00 | — | — | ||||||
| Net income | — | — | — | — | — | — | — | — | — | 1 | 2 | — | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | |||||
| Earnings | — | — | — | — | — | — | — | — | — | 0.13 | — | — | ||||||
| Cash flow | — | — | — | — | — | — | — | — | — | (0.06) | 0.00 | — | ||||||
| Capex | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | — | (0.06) | 0.00 | — | ||||||
| Book value | — | — | — | — | — | — | — | — | — | (1.11) | (1.16) | — | ||||||
| Shares, m | — | — | — | — | — | — | — | — | — | 6 | — | — | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| P/B | — | — | — | — | — | — | — | — | — | — | 0 | — | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | — | 0 | — | — | |||||
| Capex | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | — | 0 | — | — | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | — | 1 | 0 | — | |||||
| Net debt | — | — | — | — | — | — | — | — | — | (1) | (1) | — | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | — | (7) | (8) | — | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | — | 0.00 | — | — | |||||
| ROIC | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| ROE | — | — | — | — | — | — | — | — | — | 0.00 | — | — | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
Negative figures in brackets.
estimates
Dynamix Corporation III vs peers in Shell Companies (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SAMO Samos Energy Acquisition Corporation | $281.5M | — | — | — | — | — | — | — | Compare |
| XSLL Xsolla SPAC 1 | $277.4M | 46.1× | — | — | — | — | — | 0.00% | Compare |
| CEPO Cantor Equity Partners, Inc. | $275.4M | — (loss-making) | — | — | +225.00% (above 0%: growing) | 0.00% | — | 0.00% | Compare |
| SOUL Soulpower Acquisition Corporation | $275.3M | — | — | — | — | — | — | — | Compare |
| MUZE Muzero Acquisition Corp | $273.3M | — | — | — | — | — | — | — | Compare |
| DNMX Dynamix Corporation III | $271.3M | — | — | — | — | — | — | 0.00% | |
| CATL Catalyst Acquisition Corp. | $267.1M | — | — | — | — | — | — | — | Compare |
| DMAA Drugs Made In America Acquisition Corp. | $264.4M | — | — | — | — | — | — | — | Compare |
| OACC Oaktree Acquisition Corp. III Life Sciences | $262.7M | — | — | — | — | — | — | — | Compare |
| Median of peers | $274.3M | — | — | — | — | — | — | — |